Heritable Q-T Prolongation Without Deafness

Q: What is the clinical evidence from this study?

Study design: Case Report. Population: Heritable Q-T Prolongation Without Deafness. Intervention: Propranolol. Primary outcome: Prevention of ventricular arrhythmia.

Leoncio A. Garza; Robert L. Vick; James J. Nora; Dan G. McNamara

doi:10.1161/01.cir.41.1.39

January 1, 1970CirculationOpen Access

Heritable Q-T Prolongation Without Deafness

View Full Paper

Ask AI

Bookmark

Share

Why the study?

Does propranolol prevent ventricular arrhythmias in patients with heritable prolonged Q-T interval without deafness?

Key Points

To identify the inheritance pattern of familial Q-T prolongation without deafness and establish an effective prophylactic medical regimen against fatal ventricular arrhythmias.
Analyzed family pedigree transmission patterns across affected generations.
Conducted physiological provocation testing on the index patient using systemic pressure elevation, isoproterenol stimulation, and propranolol administration to evaluate arrhythmia mechanisms and therapeutic response.
Demonstrated an autosomal dominant mode of inheritance for heritable Q-T interval prolongation presenting with normal hearing.
Identified that ventricular arrhythmias were triggered by elevated systemic blood pressure, sinus tachycardia, and extrasystoles occurring during the supernormal phase of repolarization.
Established that propranolol successfully prevented ventricular arrhythmias in the index patient and relatives through direct antiarrhythmic effects rather than beta-adrenergic blockade.

Study Design

Type

Case Report

Structured PICO

Does propranolol prevent ventricular arrhythmias in patients with heritable prolonged Q-T interval without deafness?

P

Population

A family with a syndrome of heritable prolonged Q-T interval, potentially fatal episodes of ventricular arrhythmias, and normal hearing

I

Intervention

Propranolol

O

Outcome

Prevention of ventricular arrhythmiashard clinical

Propranolol is effective in preventing potentially fatal ventricular arrhythmias in patients with heritable prolonged Q-T interval without deafness.

Ask about this paper

Answers are grounded in this paper and cite their sources.

Implication

May support propranolol in rare familial long-QT without deafness; hypothesis-generating for direct antiarrhythmic effects, needing prospective confirmation.

Abstract

No abstract yet. The journal hasn't published one we can show.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Garza et al. (1970) conducted a case report in Heritable Q-T Prolongation Without Deafness. Propranolol was evaluated on Prevention of ventricular arrhythmia.

synapsesocial.com/papers/6a08cba68bd2868868ba066e https://doi.org/10.1161/01.cir.41.1.39

View Full Paper

Ask AI

Bookmark

Share

Heritable Q-T Prolongation Without Deafness

Key Points

Study Design

Structured PICO

Ask about this paper

Implication

Abstract

Discussion

Cite This Study

Heritable Q-T Prolongation Without Deafness

Key Points

Study Design

Structured PICO

Ask about this paper

Implication

Abstract

Discussion

Cite This Study

Keep reading

Keep reading